Search Results 251-260 of 11455 for total t4

  1. ... TOTAL,144,152.00, 301000033,HC ALPHA 2 MICROGLOBIN,119,#N/A,#N/A 301000034,HC ALPHA FETOPROTEIN AMNIOTIC,79,#N/A,#N/A 301000035,HC ALPHA FETOPROTEIN SERUM ...

  2. Neurology - Clinical trials

    The overall goal of PPMI is to identify markers of disease progression ... total toxicity profile. The purpose of phase 2 of this trial is to evaluate ...

  3. Texture Modified Menu Ingredient Report - Mayo Clinic

    bread, whole wheat, sliced, 1 oz, local | cheese, cheddar, mild, pre-sliced, .75 oz | cooking spray, allergen free, food release, vegalene. Turkey on WW ...

  4. Shoulder replacement surgery - Doctors & Departments - Mayo Clinic

    Total joint replacement for severe rheumatoid arthritis. https://www.uptodate.com/contents/search. Accessed April 5, 2021. Truntzer J, et al. Perioperative ...

  5. Alterations of Pulmonary Vascular System in Patients Supported By Continuous Flow Left Ventricle Assist Device (LVAD) - Mayo Clinic

    The purpose of this study is to assess the impact of continuous-flow Left Ventricle Assist Device (LVAD) therapy and total artificial heart (TAH) therapy on ...

  6. Oncology (Medical) - Clinical trials

    ... complete remission (no evidence of disease). This is an investigational ... total hysterectomy, removal of the adnexae and staging with sentinel node ...

  7. Neurology - Clinical trials

    The overall goal of PPMI is to identify markers of disease progression ... total toxicity profile. The purpose of phase 2 of this trial is to evaluate ...

  8. Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission - Mayo Clinic

    Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission.

  9. ShortStop-HER2: 12 Months Vs. 6 Months Of HER2-targeted Medications For People With HER2+ Breast Cancer Who Had A Pathologic Complete Response After Chemotherapy Plus Trastuzumab - Mayo Clinic

    ShortStop-HER2: 12 Months Vs. 6 Months Of HER2-targeted Medications For People With HER2+ Breast Cancer Who Had A Pathologic Complete Response After ...

  10. Clinical trials - Oncology (Medical)

    ... complete remission (no evidence of disease). This is an investigational ... total hysterectomy, removal of the adnexae and staging with sentinel node ...